Browsing ICR Divisions by author "Coakley, Maria"
Now showing items 1-3 of 3
-
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.
Coakley, M; Villacampa, G; Sritharan, P; Swift, C; Dunne, K; et al. (AMER ASSOC CANCER RESEARCH, 2024-02-16)PURPOSE: Detection of circulating tumor DNA (ctDNA) in patients who have completed treatment for early-stage breast cancer is associated with a high risk of relapse, yet the optimal assay for ctDNA detection is unknown. ... -
Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors.
Coakley, M; Garcia-Murillas, I; Turner, NC (AMER ASSOC CANCER RESEARCH, 2019-10)Advances in diagnosis and treatment have resulted in a high rate of survival for many patients with early-stage cancers. However, identifying who is at ongoing risk of relapse remains of high priority to direct subsequent ... -
Tracking tumour evolution through adjuvant therapy in Triple Negative Breast Cancer
Turner N; Coakley, M; Turner, N (Institute of Cancer Research (University Of London), 2024-05-20)Abstract Relapsed Triple Negative Breast Cancer (TNBC) carries a poor prognosis. Improved understanding of the molecular features of early disease, and the evolution of TNBC from early to relapsed disease, is likely to ...